PS Ratio
-1.46
+0.03+2.01%
Wed, 12 Mar 2025 13:30:00 GMT
Summary
- As of March 14, 2025, CTCX price to sales ratio is -1.46, with a rise of +0.03 (+2.01%) during the most recent trading day.
- CTCX PS ratio is now -100.05% below its all-time high of 3110.32.
Performance
CTCX PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
PS Ratio Formula
P/S = Market capitalization
TTM Revenue
Market capitalization
TTM Revenue
TTM Revenue
CTCX PS Ratio Trends
| PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | +2.0% | -2.0% | -2.0% | -10000.0% |
| 1 m1 month | -7.3% | +7.3% | +7.3% | - |
| 3 m3 months | -17.7% | +17.1% | +17.1% | -10000.0% |
| 6 m6 months | -100.2% | -45.2% | -45.2% | - |
| ytdytd | +7.6% | -8.0% | -8.0% | - |
| 1 y1 year | - | -89.0% | -90.0% | -199.1% |
| 5 y5 years | - | - | - | - |
CTCX PS Ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -32.7% | -1.81 | +19.3% | |
| 3 m | 3-month | -1.10 | -32.7% | -3.54 | +58.8% |
| 6 m | 6-month | 798.82 | -100.2% | -3.85 | +62.1% |
| 1 y | 1-year | 3110.32 | -100.0% | -3.85 | +62.1% |
| 3 y | 3-year | 3110.32 | -100.0% | -3.85 | +62.1% |
| 5 y | 5-year | 3110.32 | -100.0% | -3.85 | +62.1% |
| alltime | all time | 3110.32 | -100.0% | -3.85 | +62.1% |
Carmell Therapeutics PS Ratio History
| Date | Value |
|---|---|
| 2025 | -1.46(-7.6%) |
| Date | Value |
|---|---|
| 2024 | -1.58 |
FAQ
- What is Carmell Therapeutics price to sales ratio?
- What is the all time high PS ratio for Carmell Therapeutics?
- What is CTCX price to sales ratio year-to-date change?
What is Carmell Therapeutics price to sales ratio?
The current PS ratio of CTCX is -1.46
What is the all time high PS ratio for Carmell Therapeutics?
Carmell Therapeutics all-time high price to sales ratio is 3110.32
What is CTCX price to sales ratio year-to-date change?
Carmell Therapeutics price to sales ratio has changed by +0.12 (+7.59%) since the beginning of the year